Absence of pathogenic viruses in COVID‐19 convalescent plasma
Abstract
It is important to maintain the safety of blood products by avoiding the transfusion of units with known and novel viral pathogens. It is unknown whether COVID‐19 convalescent plasma (CCP) may contain pathogenic viruses (either newly acquired or reactivated) that are not routinely screened for by blood centers.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Nov 03, 2022
- Source ID
- 10.1111/trf.17168
Entities
People
- Aaron Tobian
- Abraham J. Kandathil
- Andrew D. Redd
- Andrew Pekosz
- Arturo Casadevall
- Ashwin Balagopal
- Daniel Hanley
- David P Sullivan
- Evan M Bloch
- Kelly A. Gebo
- Olivia Ajayi
- Patrizio P. Caturegli
- Ruchee Shrestha
- Sarah E. Benner
- Shmuel Shoham
- Thomas C. Quinn
- Xianming Zhu
Organizations
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- Johns Hopkins University
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- United States Department of Defense